7Baggers
 Neurocrine at Jefferies Conference: Growth and Strategic Plans  Investing.com Tue, 18 Nov 2025 13:20:00 GMT
 New HQ, Thriving Drugs Fueling Neurocrine Expansion  San Diego Business Journal Tue, 18 Nov 2025 13:01:15 GMT
 neurocrine biosciences to present at upcoming investor conferences  Your Wyoming Link Wed, 12 Nov 2025 20:01:58 GMT
 Neurocrine Biosciences to Present at Upcoming Investor Conferences  Yahoo Finance Tue, 11 Nov 2025 21:01:00 GMT
 neurocrine’s depression drug misses in phase ii  Citeline News & Insights Tue, 11 Nov 2025 13:56:51 GMT
 morgan stanley lowers price target for neurocrine biosciences (n  GuruFocus Tue, 11 Nov 2025 13:38:09 GMT
 Neurocrine’s depression treatment misses main goal in Phase II study  Clinical Trials Arena Tue, 11 Nov 2025 10:37:02 GMT
 neurocrine’s depression drug fails to meet primary endpoint in phase 2 by investing.com  Investing.com South Africa Tue, 11 Nov 2025 03:58:12 GMT
 Neurocrine chalks up a depression drug failure  BioPharma Dive Mon, 10 Nov 2025 23:26:22 GMT
 Neurocrine Biosciences fails mid-stage study of depression drug  Seeking Alpha Mon, 10 Nov 2025 22:01:11 GMT
 understanding the setup: (nbix) and scalable risk  news.stocktradersdaily.com Fri, 07 Nov 2025 19:38:02 GMT
 Stocks Showing Rising Market Leadership: Neurocrine Biosciences Earns 83 RS Rating  Investor's Business Daily Fri, 07 Nov 2025 08:00:00 GMT
 earnings estimates rising for neurocrine (nbix): will it gain?  Yahoo Finance Thu, 06 Nov 2025 17:20:02 GMT
 neurocrine biosciences stock reaches 52-week high at 154.83 usd by investing.com  Investing.com Nigeria Thu, 06 Nov 2025 10:39:04 GMT
 Neurocrine Biosciences Clears Key Benchmark, Hitting 80-Plus RS Rating  Investor's Business Daily Thu, 06 Nov 2025 08:00:00 GMT
 neurocrine biosciences, inc. $nbix shares sold by burney co.  MarketBeat Wed, 05 Nov 2025 10:17:52 GMT
 Neurocrine Biosciences stock reaches 52-week high at 154.83 USD  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 why neurocrine biosciences stock is climbing higher  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 neurocrine biosciences ceo gano kyle sells $42591 in stock by investing.com  Investing.com Australia Wed, 05 Nov 2025 08:00:00 GMT

Neurocrine Biosciences, Inc
(NASDAQ:NBIX) 

NBIX stock logo

Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric-based diseases and disorders in the United States. The company offers INGREZZA, a VMAT2 inhibitor for the treatment of tar...

Founded: 1992
Full Time Employees: 825
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends